Eagle Pharmaceuticals, Inc. Other Non-Current Liabilities
Eagle Pharmaceuticals, Inc. had Other Non-Current Liabilities of $4.26 million as of 2023-06-30, per its 10-Q/A filed 2023-08-09.
Discontinued › Balance Sheet › Liabilities › Liabilities, Noncurrent › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2023-08-09
- 2023-06-30: Other Liabilities, Noncurrent $4.26M.
- 2023-03-31: Other Liabilities, Noncurrent $4.69M.
- 2022-12-31: Other Liabilities, Noncurrent $5.30M.
- 2022-09-30: Other Liabilities, Noncurrent $1.87M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2023-06-30 | $4.26M 10-Q/A · filed 2023-08-09 |
| 2023-03-31 | $4.69M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $5.30M 10-Q/A · filed 2023-08-09 |
| 2022-09-30 | $1.87M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $2.26M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $2.56M 10-Q · filed 2022-05-09 |
| 2021-12-31 | $2.90M 10-K · filed 2023-03-23 |
| 2021-09-30 | $3.05M 10-Q · filed 2021-11-09 |
| 2021-06-30 | $3.36M 10-Q · filed 2021-08-09 |
| 2021-03-31 | $3.66M 10-Q · filed 2021-05-10 |
| 2020-12-31 | $3.96M 10-K · filed 2022-03-08 |
| 2020-09-30 | $2.84M 10-Q · filed 2020-11-02 |
| 2020-06-30 | $3.36M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $3.45M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $3.00M 10-K · filed 2021-03-05 |
| 2019-09-30 | $3.23M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $1.56M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $2.87M 10-Q · filed 2019-05-07 |
| 2018-12-31 | $0.00 10-K · filed 2020-03-02 |